| Document |
Document Title |
|
JP2021178814A |
To provide a salt and an acid generator which make it possible to produce a resist pattern with excellent mask error factor (MEF) and a resist composition comprising the same.The present invention discloses a salt represented by, for exa...
|
|
JP2021176846A |
To provide HBV inhibitors that have additional advantages such as increased potency or an increased safety window.There are provided sulfamoyl aryl amides represented by following formula, a stereoisomer or a tautomeric form thereof, or ...
|
|
JP2021176912A |
To provide integrated processes that achieve improved carbon efficiency for processes based on coal or biomass gasification or steam methane reforming.Methods for producing beta propiolactone includes: a step (a) of, in a first reaction ...
|
|
JP6959726B2 |
To provide a compound which makes it possible to produce a resist pattern with excellent focus margin (DOF), and a resin and a resist composition comprising the same.The present invention provides a compound represented by formula (I), a...
|
|
JP6959727B2 |
To provide a salt capable of producing a resist pattern in a good shape, an acid generator, and a resist composition containing the same.The salt represented by formula (I), the acid generator, and the resist composition are provided. [I...
|
|
JP2021529818A |
A core unit, five generations of a lysine residue or an analog building unit thereof, a first terminal group containing a cavazitazel residue covalently attached to a diglycolyl linker group, and a second terminal group containing a PEG ...
|
|
JP6953408B2 |
The invention relates to a compound of formula (I)wherein R1 to R3 are defined as in the description and in the claims. The compound of formula (I) can be used as a medicament.
|
|
JP6947781B2 |
Provided herein are compounds of formula I:wherein the variables are defined herein, processes of making them, and methods of treating cancer comprising administering such compounds.
|
|
JP6942141B2 |
The present technology relates generally to oligolactic acid conjugates of paclitaxel, rapamycin, selumetinib, and other anticancer agents, micelle compositions containing such conjugates and methods of preparing and using such compositi...
|
|
JP2021523200A |
Pharmaceutical compositions containing piperazine carbamate and said compounds are provided herein. This compound and composition are useful as MAGL regulators. In addition, the compounds and compositions are useful in the treatment of p...
|
|
JP6889663B2 |
This disclosure relates to the field of molecules having pesticidal utility against pests in Phyla Arthropoda, Mollusca, and Nematoda, processes to produce such molecules, intermediates used in such processes, pesticidal compositions con...
|
|
JP2021513547A |
Provided are compounds that function as thyroid hormone mimetics, which are useful for treating diseases such as neurodegenerative diseases. Along with pharmaceutical compositions containing such compounds, methods of use and preparation...
|
|
JP2021073200A |
To provide novel carrier compositions for efficiently delivering a therapeutic agent, diagnostic agent, or targeting agent to a therapeutic site, in the treatment of diseases such as cancer, or in vivo diagnosis.Provided is a carrier com...
|
|
JP6861943B2 |
To provide a photopolymerization sensitizer that prevents migration from occurring at photocuring or during storage of a cured product.The present invention provides an anthracene compound having a (3-methyloxetane-3-yl)methyloxy group r...
|
|
JP6843352B2 |
To provide a curable composition that can form a cured product with a high refractive index, and a cured product of the curable composition.A curable composition has a cationic polymerizable compound, and polysilane. The cationic polymer...
|
|
JP2021506988A |
The present invention is directed to methods for producing biodegradable polyester polyol polymers with high biobase content and biodegradable polyester polyol polymers with high biobase content. In a preferred embodiment, the β-lactone...
|
|
JP2021505573A |
Aspects of the present disclosure include conformationally constrained analogs of catecholamine-type compounds (eg, isoprenaline, adrenaline, noradrenaline) that activate β2AR with high selectivity above β1AR. The subject beta-2 select...
|
|
JP2021505586A |
Equation (I)Compounds (in the formula, substituents are as defined in claim 1). In addition, the present invention relates to horticultural chemical compositions containing compounds of formula (I), the preparation of these compositions,...
|
|
JP6820057B2 |
The present specification relates to a coating composition comprising a compound represented by Chemical Formula 1; and an ionic compound comprising an anion group represented by Chemical Formula 10, an organic light emitting device usin...
|
|
JP6790040B2 |
The present invention relates to a list of specific 2-hydroxy-1-{4-[(4-phenylphenyl)carbonyl]piperazin-1-yl}etha
n-1-one derivatives and related compounds as fatty acid synthase (FAS or FASN) inhibitors for treating cancer and pharmacuti...
|
|
JP6773815B2 |
This invention discloses a group of polyfunctional oxetane-based compounds and a production method thereof. These compounds are compounds having a structure as represented by general formula (I) or a product obtained by a reaction betwee...
|
|
JP6772549B2 |
To provide a polymerizable composition that causes few orientation defects when added to a polymerizable composition and making a film-like polymer, and is resistant to discoloration when put in a high temperature condition.The present i...
|
|
JP2020152641A |
To provide a novel compound having high lysine-specific demethylating enzyme (LSD) 1 inhibitory activity, high selectivity for LSD1 inhibition, and/or useful therapeutic effects on various diseases.The present invention relates to a comp...
|
|
JP6758669B2 |
An object of the present invention is to provide a novel ascochlorin derivative which activates adenosine monophosphate-activated protein kinase (AMPK), and is useful in the treatment or prevention of diseases or conditions that involve ...
|
|
JP6754778B2 |
The present invention relates to compounds according to Formula I : or a pharmaceutically acceptable salt thereof wherein the variables have the meanings defined in the claims. The compounds can be used as inhibitors of ROR³ and are use...
|
|
JP2020522553A |
The present invention relates to substituted crosslinked cycloalkane derivatives. Specifically, the present invention is a compound according to formula IIIQ: [Chemical 1](In the formula, X6’, A, b, C8’, D8’, L82’, L83’, R81’...
|
|
JP6721873B2 |
The spontaneous orientation aid for a liquid crystal composition provides storage stability and allows liquid crystal molecules to be vertically aligned without a PI layer when added to a liquid crystal composition. When used in a liquid...
|
|
JP2020517600A |
Among other things, methods and compounds for regulating K-Ras and for treating cancer are provided herein.
|
|
JP6698803B2 |
The present invention relates to a new anhydrous crystalline form of Cabazitaxel of formula (I), designated as form H. A further object of the present invention is a processes for the preparation of the above mentioned form H by recrysta...
|
|
JP6693425B2 |
Provided is a polar compound that has high chemical stability and high capability of aligning liquid crystal molecules, and has a large voltage holding ratio when used in a liquid crystal display device.The compound represented by formul...
|
|
JP6683709B2 |
Benzenesulfonamide derivatives of formula (I), the pharmaceutically acceptable addition salts thereof, the hydrates and/or solvates thereof, and the use of same as inverse agonist of retinoid-related orphan receptor gamma (RORγt) are de...
|
|
JP6680910B2 |
This invention discloses a hybrid photosensitive resin and a preparation method thereof. This hybrid photosensitive resin has a structure represented by general formula (I) and contains an oxetanyl functional group and a (meth)acryloxy f...
|
|
JP2020506203A |
A potent 5-HT2B antagonist of formula (A), its stereochemical isomer form, and a potent 5-HT2B antagonist of formula (A), including salts, hydrates, solvates, and Use of R1 through R4 and Ar having the meaning as defined herein. The pres...
|
|
JP2020019814A |
To provide compounds and methods for inhibiting histone deacetylase enzymes ("HDAC") (e.g., HDAC1, HDAC2 and HDAC3).The invention provides a compound with a structure of formula (II) or a pharmaceutically acceptable salt thereof. (In the...
|
|
JP6636031B2 |
and salts thereof and compositions and uses thereof. The compounds are useful as inhibitors of LSD1. Also included are pharmaceutical compositions comprising a compound of formula I or a pharmaceutically acceptable salt thereof, and meth...
|
|
JP6636014B2 |
The present invention provides compounds of Formula (I) and (II) as described herein, and salts thereof, and therapeutic uses of these compounds for treatment of disorders associated with Raf kinase activity. The invention further provid...
|
|
JP2020502189A |
IDO inhibitor compounds of formula (I) and their pharmaceutically acceptable salts, their pharmaceutical compositions, their preparation methods, and chronic viral infections, chronic bacterial infections, cancer, sepsis or neurological ...
|
|
JP6634692B2 |
|
|
JP2020500850A |
Compound of formula (I)(In the formula, R1, R2, R3, R4, And R5Is provided as defined in claim 1). In addition, the present invention relates to horticultural chemical compositions containing compounds of formula (I), the preparation of t...
|
|
JP2019218335A |
To provide a compound, a resin, and a resist composition capable of producing a resist pattern having good line edge roughness (LER).The compound is represented by formula (IA) or formula (IB), and the resin and the resist composition co...
|
|
JP6625197B2 |
A method for analyzing related substances in a pharmaceutical composition containing an amphiphilic block copolymer comprising a hydrophilic block and a hydrophobic block as a polymeric drug carrier, related substances identified thereby...
|
|
JP6622824B2 |
Certain compounds, or pharmaceutically acceptable salts or prodrugs thereof, pharmaceutical compositions comprising the same and methods of treating patients suffering from certain diseases and disorders response to the inhibition of KMO...
|
|
JP2019210263A |
To provide a polymerizable compound having high liquid crystallinity and less likely causing crystallization when added to a polymerizable composition and stored for a long period of time, to provide a polymerizable composition containin...
|
|
JP2019210248A |
To provide a surface modifier that makes it possible to obtain a surface having excellent water-sliding properties, and a curable resin composition using the same, and a water-sliding coating film using the same.Used herein is a calixare...
|
|
JP6607924B2 |
Disclosed are compounds of Formulas (I), (II), (III), (IV), and (V):and/or a salt thereof, wherein R1 is —OH or —OP(O)(OH)2, and X1, X2, X3, R2, R2a, Ra, Rb, and Rc are defined herein. Also disclosed are methods of using such compoun...
|
|
JP2019182869A |
To provide novel methods for treating or preventing diseases or conditions associated with the enzyme glucosylceramide synthase (GCS).Described herein are compounds of formula I, methods of making such compounds, pharmaceutical compositi...
|
|
JP6580598B2 |
The invention relates to 1-(3-sulfonylphenyl)-3-(cyclopent-2-en-1-yl)urea derivatives, and their use in treating or preventing diseases and conditions mediated by the CXCR2 receptor. In addition, the invention relates to compositions con...
|
|
JP2019116486A |
To provide a method for continuous carbonylation of an epoxide or lactone feedstock.There is provided a method for monitoring and maintaining continuous carbonylation of an epoxide or lactone feedstock. The method includes measuring para...
|
|
JP6533794B2 |
The present invention provides taxanes compounds with a formula (I) or formula (II) structure, a method for preparing the compounds, as well as the use of the compositions containing the compounds, pharmaceutically acceptable salts and s...
|
|
JP6529519B2 |
A problem of the present invention is to provide a polymerizable compound and a polymerizable composition which cause little decrease in retardation and discoloration when a film-shaped polymer produced by polymerization is irradiated wi...
|
